Medical and Pharmaceutical Cancer remains Canada’s top killer as 2026 cases exceed 254,000 Age-standardized death rates are projected to decline overall Joseph MortonApril 17, 2026
Medical and Pharmaceutical Inovio advances DNA medicine for debilitating respiratory condition The FDA acknowledged that the therapy could support a Biologics License Application under its accelerated approval program Joseph MortonAugust 28, 2025
Medical and Pharmaceutical Phase Scientific International advances urine biopsy tech with $34M fundraising round The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories Joseph MortonMay 26, 2025
Medical and Pharmaceutical Screenings for lung and cervical cancer are increasing in Canada Lung cancer remains the leading cause of cancer-related deaths in Canada, effecting one in 14 Canadians Joseph MortonOctober 18, 2024